Gender-Disparities in the in-Hospital Clinical Outcome Among Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention

References

• Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492. doi:10.1161/CIR.0000000000000558
   PubMed Web of Science ®Google Scholar
• Moran AE, Forouzanfar MH, Roth GA, et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129(14):1493–1501. doi:10.1161/CIRCULATIONAHA.113.004046
   PubMed Web of Science ®Google Scholar
• Liu S, Li Y, Zeng X, et al. Burden of cardiovascular diseases in China, 1990–2016: findings from the 2016 Global Burden of Disease Study. JAMA cardiol. 2019;4(4):342. doi:10.1001/jamacardio.2019.0295
   PubMed Web of Science ®Google Scholar
• Wagner M, Wanner C, Kotseva K, et al. Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries: insights from the EUROASPIRE IV survey of the European Society of Cardiology. Eur J Prev Cardiol. 2017;24(11):1168–1180. doi:10.1177/2047487317708891
   PubMed Web of Science ®Google Scholar
• Sun X, He J, Ji XL, et al. Association of chronic kidney disease with coronary heart disease and stroke risks in patients with type 2 diabetes mellitus: an observational cross-sectional study in Hangzhou, China. Chin Med J. 2017;130(1):57–63. doi:10.4103/0366-6999.196564
   PubMed Web of Science ®Google Scholar
• Agrawal H, Aggarwal K, Littrell R, et al. Pharmacological and non pharmacological strategies in the management of coronary artery disease and chronic kidney disease. Curr Cardiol Rev. 2015;11(3):261–269. doi:10.2174/1573403X1103150514155757
   PubMedGoogle Scholar
• Burlacu A, Genovesi S, Goldsmith D, et al. Bleeding in advanced CKD patients on antithrombotic medication - A critical appraisal. Pharmacol Res. 2018;129:535–543. doi:10.1016/j.phrs.2017.12.004
   PubMed Web of Science ®Google Scholar
• Ali S, Dave N, Virani SS, Navaneethan SD. Primary and secondary prevention of cardiovascular disease in patients with chronic kidney disease. Curr Atheroscler Rep. 2019;21(9):32. doi:10.1007/s11883-019-0794-6
   PubMed Web of Science ®Google Scholar
• Su X, Yan B, Wang L, Lv J, Cheng H, Chen Y. Effect of antiplatelet therapy on cardiovascular and kidney outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol. 2019;20(1):309. doi:10.1186/s12882-019-1499-3
   PubMed Web of Science ®Google Scholar
• Wu Y, Song Y, Pan Y, Gong Y, Zhou Y. Long-term and short-term duration of thienopyridine therapy after coronary stenting in patients with chronic kidney disease a meta-analysis of literature studies. Platelets. 2019;30(1):1–7. doi:10.1080/09537104.2019.1549810
   PubMed Web of Science ®Google Scholar
• Cai A, Wu Z, Xu L, et al. Association of anaemia and all-cause mortality in patients with ischaemic heart failure varies by renal function status. ESC Heart Fail. 2021;8(3):2270–2281. doi:10.1002/ehf2.13325
   PubMed Web of Science ®Google Scholar
• Bonello L, Angiolillo DJ, Aradi D, Sibbing D. P2Y12-ADP receptor blockade in chronic kidney disease patients with acute coronary syndromes. Circulation. 2018;138:1582–1596. doi:10.1161/CIRCULATIONAHA.118.032078
   PubMed Web of Science ®Google Scholar
• Bonello L, Laine M, Lemesle G, et al. Meta-analysis of potent P2Y12-ADP receptor antagonist therapy compared to clopidogrel therapy in acute coronary syndrome patients with chronic kidney disease. Thromb Haemost. 2018;118(10):1839–1846. doi:10.1055/s-0038-1669426
   PubMed Web of Science ®Google Scholar
• Rymer JA, Kaltenbach LA, Doll JA, Messenger JC, Peterson ED, Wang TY. Safety of dual-antiplatelet therapy after myocardial infarction among patients with chronic kidney disease. J Am Heart Assoc. 2019;8(10):e012236. doi:10.1161/JAHA.119.012236
   PubMed Web of Science ®Google Scholar
• Aggarwal NR, Patel HN, Mehta LS, et al. Sex differences in ischemic heart disease: advances, obstacles, and next steps. Circ Cardiovasc Qual Outcomes. 2018;11(2):e004437. doi:10.1161/CIRCOUTCOMES.117.004437
   PubMed Web of Science ®Google Scholar
• Alabas OA, Gale CP, Hall M, et al. Sex differences in treatments, relative survival, and excess mortality following acute myocardial infarction: national cohort study using the SWEDEHEART registry. J Am Heart Assoc. 2017;6(12). doi:10.1161/JAHA.117.007123
   Web of Science ®Google Scholar
• Hess CN, Kaltenbach LA, Doll JA, Cohen DJ, Peterson ED, Wang TY. Race and sex differences in post-myocardial infarction angina frequency and risk of 1-year unplanned rehospitalization. Circulation. 2017;135(6):532–543. doi:10.1161/CIRCULATIONAHA.116.024406
   PubMed Web of Science ®Google Scholar
• Hao Y, Liu J, Liu J, et al. Sex differences in in-hospital management and outcomes of patients with acute coronary syndrome. Circulation. 2019;139(15):1776–1785. doi:10.1161/CIRCULATIONAHA.118.037655
   PubMed Web of Science ®Google Scholar
• Chen Y, Jiang L, Smith M, et al. Sex differences in hospital mortality following acute myocardial infarction in China: findings from a study of 45 852 patients in the COMMIT/CCS-2 study. Heart Asia. 2011;3(1):104–110. doi:10.1136/heartasia-2011-010003
   PubMedGoogle Scholar
• Hebert K, Dias A, Delgado MC, et al. Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population. Eur J Heart Fail. 2010;12(8):861–865. doi:10.1093/eurjhf/hfq077
   PubMed Web of Science ®Google Scholar
• WHOE Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163.
   PubMed Web of Science ®Google Scholar
• Liu LS, Wu ZS, Wang JG, etal. 2018 Chinese guidelines for prevention and treatment of hypertension-A report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16:182–241.
   PubMedGoogle Scholar
• Jun-Ren ZH, Run-Lin GA, Shui-Ping ZH, et al. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol. 2018;15(1):1–29. doi:10.11909/j.issn.1671-5411.2018.01.011
   PubMedGoogle Scholar
• Jia W, Weng J, Zhu D, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35(6):e3158–e3158. doi:10.1002/dmrr.3158
   PubMed Web of Science ®Google Scholar
• Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736–2747. doi:10.1161/CIRCULATIONAHA.110.009449
   PubMed Web of Science ®Google Scholar
• Roswell RO, Kunkes J, Chen AY, et al. Impact of sex and contact-to-device time on clinical outcomes in acute ST-segment elevation myocardial infarction-findings from the national cardiovascular data registry. J Am Heart Assoc. 2017;6(1). doi:10.1161/JAHA.116.004521
   PubMed Web of Science ®Google Scholar
• Kunadian V, Qiu W, Lagerqvist B, et al. Gender differences in outcomes and predictors of all-cause mortality after percutaneous coronary intervention (Data from United Kingdom and Sweden). Am J Cardiol. 2017;119(2):210–216. doi:10.1016/j.amjcard.2016.09.052
   PubMed Web of Science ®Google Scholar
• Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: executive summary: a REport of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;78(22):Cir0000000000001030.
   Google Scholar
• Wannamethee SG, Papacosta O, Lawlor DA, et al. Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women’s Heart Health Study. Diabetologia. 2012;55(1):80–87. doi:10.1007/s00125-011-2284-4
   PubMed Web of Science ®Google Scholar
• Juutilainen A, Kortelainen S, Lehto S, et al. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care. 2004;27(12):2898–2904. doi:10.2337/diacare.27.12.2898
   PubMed Web of Science ®Google Scholar
• Cai T, Abel L, Langford O, et al. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses. BMJ. 2021;374:n1537. doi:10.1136/bmj.n1537
   PubMed Web of Science ®Google Scholar
• Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2018;2019(40):87–165.
   Google Scholar
• Cesaro A, Taglialatela V, Gragnano F, et al. Low-dose ticagrelor in patients with high ischemic risk and previous myocardial infarction: a multicenter prospective real-world observational study. J Cardiovasc Pharmacol. 2020;76(2):173–180. doi:10.1097/FJC.0000000000000856
   PubMed Web of Science ®Google Scholar
• Andò G, Gragnano F, Calabrò P, Valgimigli M. Radial vs femoral access for the prevention of acute kidney injury (AKI) after coronary angiography or intervention: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2018;92(7):E518–e526. doi:10.1002/ccd.27903
   PubMed Web of Science ®Google Scholar
• Cesaro A, Moscarella E, Gragnano F, et al. Transradial access versus transfemoral access: a comparison of outcomes and efficacy in reducing hemorrhagic events. Expert Rev Cardiovasc Ther. 2019;17(6):435–447. doi:10.1080/14779072.2019.1627873
   PubMed Web of Science ®Google Scholar
• Xu N, Tang XF, Zhao XY, et al. Sex-based differences in bleeding and long-term adverse events after percutaneous coronary intervention in older patients with coronary artery disease. J Interv Cardiol. 2018;31(3):345–352. doi:10.1111/joic.12500
   PubMed Web of Science ®Google Scholar
• Wanha W, Kawecki D, Roleder T, et al. Gender differences and bleeding complications after PCI on first and second generation DES. Scand Cardiovasc J. 2017;51(1):53–60. doi:10.1080/14017431.2016.1219044
   PubMed Web of Science ®Google Scholar
• Vogel B, Chandrasekhar J, Baber U, et al. Geographical variations in patterns of DAPT cessation and two-year PCI outcomes: insights from the Paris Registry. Thromb Haemost. 2019;119(10):1704–1711.
   PubMed Web of Science ®Google Scholar
• Shimizu A, Sonoda S, Muraoka Y, et al. Bleeding and ischemic events during dual antiplatelet therapy after second-generation drug-eluting stent implantation in hemodialysis patients. J Cardiol. 2019;73(6):470–478. doi:10.1016/j.jjcc.2018.12.009
   PubMed Web of Science ®Google Scholar
• Kim SH, Behnes M, Baron S, et al. Differences of bleedings after percutaneous coronary intervention using femoral closure and radial compression devices. Medicine. 2019;98(20):e15501. doi:10.1097/MD.0000000000015501
   PubMed Web of Science ®Google Scholar
• Kang J, Park KW, Palmerini T, et al. Racial differences in ischaemia/bleeding risk trade-off during anti-platelet therapy: individual patient level landmark meta-analysis from seven RCTs. Thromb Haemost. 2019;119(01):149–162. doi:10.1055/s-0038-1676545
   PubMed Web of Science ®Google Scholar
• Janssen PWA, Bergmeijer TO, Vos GA, et al. Tailored P2Y12 inhibitor treatment in patients undergoing non-urgent PCI-the POPular risk score study. Eur J Clin Pharmacol. 2019;75(9):1201–1210. doi:10.1007/s00228-019-02696-z
   PubMed Web of Science ®Google Scholar